Brice Maxime Hugues Ozenne

Brice Maxime Hugues Ozenne

Associate Professor


  1. 2016
  2. An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

    Péron, J., Roy, P., Conroy, T., Desseigne, F., Ychou, M., Gourgou-Bourgade, S., Stanbury, T., Roche, L., Ozenne, Brice Maxime Hugues & Buyse, M., 19 Oct 2016, In: OncoTarget.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring

    Péron, J., Buyse, M., Ozenne, Brice Maxime Hugues, Roche, L. & Roy, P., 2 Aug 2016, In: Statistical Methods in Medical Research.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials

    Péron, J., Roy, P., Ozenne, Brice Maxime Hugues, Roche, L. & Buyse, M., 1 Jul 2016, In: JAMA Oncology. 2, 7, p. 901-905 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 144764824